Literature DB >> 30912000

Is echocardiography mandatory for patients with chronic kidney disease?

Emilio Nardi1, Giuseppe Mulè2, Chiara Nardi2, Giulio Geraci2, Antonina Giammanco2, Riccardo Bentivegna2, Maurizio Averna2.   

Abstract

This study aims at evaluating the prevalence of left ventricular diastolic dysfunction in a group of 319 hypertensive patients with stage 3b-4-5 chronic kidney disease (according to Kidney Disease Improving Global Outcomes classification), compared with 216 patients with essential hypertension and normal renal function. All patients underwent echocardiographic examination. Patients on stage 1-2-3a chronic kidney disease, dialysis treatment, or with previous manifestations of heart failure or other cardiovascular diseases were excluded. Patients with renal disease had significantly worse diastolic function (both considering trans-mitral flow and tissue Doppler imaging parameters). Diastolic dysfunction is found in 70.5% of the CKD group and in 41.6% of hypertensive patients (p < 0.0001). Multiple regression analysis shows an association between renal function and diastolic function (β 0.223; p < 0.0001), independent of potential confounders. Our study shows that diastolic dysfunction is highly prevalent in patients with advanced chronic kidney disease; we posit that in this population, the risk of diastolic heart failure is very high. We think that patients with a marked decrease of glomerular filtration rate (GFR) must be considered at high risk for diastolic heart failure and should have an echocardiographic examination performed, even if asymptomatic and in the absence of evident cardiovascular disease.

Entities:  

Keywords:  Chronic kidney disease; Diastolic function; Heart failure; Hypertension

Mesh:

Year:  2019        PMID: 30912000     DOI: 10.1007/s11739-019-02028-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  28 in total

1.  Assessing diagnosis in heart failure: which features are any use?

Authors:  A P Davie; C M Francis; L Caruana; G R Sutherland; J J McMurray
Journal:  QJM       Date:  1997-05

Review 2.  Diagnosis of heart failure in primary care.

Authors:  Cândida Fonseca
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

3.  The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure.

Authors:  Johannes C Kelder; Maarten J Cramer; Jan van Wijngaarden; Rob van Tooren; Arend Mosterd; Karel G M Moons; Jan W Lammers; Martin R Cowie; Diederick E Grobbee; Arno W Hoes
Journal:  Circulation       Date:  2011-11-21       Impact factor: 29.690

4.  Cystatin C concentration as a risk factor for heart failure in older adults.

Authors:  Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

5.  Associations between kidney function and subclinical cardiac abnormalities in CKD.

Authors:  Meyeon Park; Chi-yuan Hsu; Yongmei Li; Rakesh K Mishra; Martin Keane; Sylvia E Rosas; Daniel Dries; Dawei Xie; Jing Chen; Jiang He; Amanda Anderson; Alan S Go; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2012-08-30       Impact factor: 10.121

Review 6.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

7.  Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Authors:  Michael G Shlipak; Ronit Katz; Mark J Sarnak; Linda F Fried; Anne B Newman; Catherine Stehman-Breen; Stephen L Seliger; Brian Kestenbaum; Bruce Psaty; Russell P Tracy; David S Siscovick
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

8.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

Review 9.  Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.

Authors:  J Mant; J Doust; A Roalfe; P Barton; M R Cowie; P Glasziou; D Mant; R J McManus; R Holder; J Deeks; K Fletcher; M Qume; S Sohanpal; S Sanders; F D R Hobbs
Journal:  Health Technol Assess       Date:  2009-07       Impact factor: 4.014

10.  Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Authors:  Anna Kottgen; Stuart D Russell; Laura R Loehr; Ciprian M Crainiceanu; Wayne D Rosamond; Patricia P Chang; Lloyd E Chambless; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2007-03-07       Impact factor: 10.121

View more
  1 in total

1.  Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study.

Authors:  Francesco Spannella; Marco Marini; Federico Giulietti; Giulia Rosettani; Matteo Francioni; Gian Piero Perna; Riccardo Sarzani
Journal:  Intern Emerg Med       Date:  2019-05-30       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.